Evaluating Major Bleeding Risks with Concomitant Use of Direct Oral Anticoagulants and Selective Serotonin Reuptake Inhibitors in Nonvalvular Atrial Fibrillation Patients
Background/Objectives: Direct oral anticoagulants (DOACs), when compared to the Vitamin K antagonist (VKA) warfarin, exhibit greater safety and effectiveness. However, DOACs may still have potential drug–drug interactions that result in major bleeding events. There is a paucity of studies on medicat...
Saved in:
| Main Authors: | Shu-Yu Yao, Paul T. Kocis, Terrence E. Murphy, Wenke Hwang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Pharmacoepidemiology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2813-0618/4/1/6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bleeding Associated With Antiarrhythmic Drugs in Patients With Atrial Fibrillation Using Direct Oral Anticoagulants: A Nationwide Population Cohort Study
by: Victor Chien‐Chia Wu, et al.
Published: (2024-11-01) -
A Narrative Review: Serotonin Reuptake Inhibitors and the Risk of Suicidal Ideation in Adolescents
by: Dylan S. Gage, et al.
Published: (2025-02-01) -
Predictive thresholds of peak and trough anti-Xa levels for bleeding risk in rivaroxaban-treated nonvalvular atrial fibrillation
by: Mouhammad Rida Almouwannes, et al.
Published: (2025-08-01) -
Association of Body Mass Index with Echocardiographic Parameters and Incidence of Left Atrial Thrombus or Spontaneous Echo Contrast in Patients with Nonvalvular Atrial Fibrillation: A Cross-Sectional Study
by: Yi Qiu, et al.
Published: (2024-12-01) -
Concomitant Drug Interactions With Non–Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation
by: Chun‐Ka Wong, et al.
Published: (2025-05-01)